RaginiKudchadkarMD

PubMed

• Cutaneous and Noncutaneous Adverse Effects in Patients with Advanced Melanoma Receiving Immunotherapy.
  Howa Yeung, Krittin J Supapannachart, Sandy Francois, Colin H Adler, Ragini R Kudchadkar, David H Lawson, Melinda L Yushak, Afreen I Shariff, Suephy C Chen> ;JID Innovations. 2023 Nov 1
• 1 citations
  FcγRIIB expressed on CD8T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.
  Kelsey B Bennion, Marvi Tariq, Megan M Wyatt, Charlotte Duneton, Kirsten M Baecher, Chrystal M Paulos, Ragini R Kudchadkar, Michael C Lowe, Mandy L Ford> ;Science Translational Medicine. 2023 Aug 23
• 3 citations
  Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
  Nikhil I Khushalani, Melinda Vassallo, Judith D Goldberg, Zeynep Eroglu, Younchul Kim, Biwei Cao, Robert Ferguson, Kelsey R Monson, Tomas Kirchhoff, Carol M Amato, Pau...> ;Journal for Immunotherapy of Cancer. 2022 Nov 1
• 2 citations
  A Safety Analysis of Programmed Death 1 Pathway Inhibitors in Patients With Solid Tumor Malignancies and Preexisting Autoimmune Disease.
  Jordyn Paige Higgins, Anh Viet Trinh, Marley L Watson, Tyler Beardslee, Subir Goyal, Ragini Kudchadkar, Suchita Pakkala, Jonathan Waltuck, Kathryn Momary, Kristina F B...> ;Journal of Clinical Rheumatology. 2022 Oct 1
• 1 citations
  Case Report: Delayed Onset Multi-Organ Toxicities in a Melanoma Patient Achieving Complete Response to BRAF/MEK Inhibition.
  Hannah M Knochelmann, Michael Brandon Ware, Aditya Rali, Susanne Linderman, Jessica G Shantha, David H Lawson, Melinda Yushak, Robert Swerlick, Chrystal M Paulos, Stev...> ;Frontiers in Oncology. 2022 Jan 1
• 7 citations
  Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry.
  Aleksandar Sekulic, Simon Yoo, Ragini Kudchadkar, Julie Guillen, Gary Rogers, Anne Lynn S Chang, Scott Guenthner, Bernard Raskin, Keith Dawson, Yong Mun, Laura Chu, Ed...> ;Plos One. 2022 Jan 1
• 61 citations
  Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a si...
  David C. Qian, Troy Kleber, Brianna Brammer, Karen M. Xu, Jeffrey M. Switchenko, James Janopaul-Naylor, Jim Zhong, Melinda L. Yushak, R. Donald Harvey, Chrystal M. Pau...> ;The Lancet. Oncology. 2021 Nov 12
• 17 citations
  Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma.
  Kenneth F. Grossmann, Megan Othus, Sapna Pradyuman Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp, Teresa M. Petrella, Thach-Giao Truong, Nikhil I. Khusha...> ;Cancer Discovery. 2021 Nov 11
• 98 citations
  Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label...
  Hussein Abdul-Hassan Tawbi, Peter A. Forsyth, F. Stephen Hodi, Alain Algazi, Omid Hamid, Christopher D. Lao, Stergios J. Moschos, Michael B. Atkins, Karl D. Lewis, Mic...> ;The Lancet. Oncology. 2021 Nov 10
• 17 citations
  Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete rese...
  Alexander M.M. Eggermont, Andrey Meshcheryakov, Victoria Atkinson, Christian U. Blank, Mario Mandalà, Georgina V. Long, Catherine Barrow, Anna Maria Di Giacomo, Rosali...> ;European Journal of Cancer. 2021 Oct 18
• 54 citations
  Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
  Hussein Abdul-Hassan Tawbi, Peter A. Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid, Michael B. Atkins, Karl D. Lewis, Reena Thomas, Joh...> ;Neuro-Oncology. 2021 Apr 21
• 183 citations
  Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomi...
  Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Meshcheryakov, Adnan Khattak, M...> ;The Lancet. Oncology. 2021 May 1
• 32 citations
  Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomise...
  Andrew Bottomley, Corneel Coens, Justyna Mierzynska, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Andrey Mesh...> ;The Lancet. Oncology. 2021 May 1
• 48 citations
  Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
  Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl, Philip Friedlander, Adil Daud, Harriet M. Kluger, Sunil Red...> ;Journal for Immunotherapy of Cancer. 2021 Apr 1
• 5 citations
  The Impact of Obesity on Surgically Treated Locoregional Melanoma.
  Constance Harrell Shreckengost, Marvi Tariq, Clara R. Farley, Chao Zhang, Keith A. Delman, Ragini R. Kudchadkar, Michael C. Lowe> ;Annals of Surgical Oncology. 2021 Mar 14
• 18 citations
  The evolving landscape of immunotherapy in solid tumors.
  Jessica M Keilson, Hannah M. Knochelmann, Chrystal M. Paulos, Ragini R. Kudchadkar, Michael C. Lowe> ;Journal of Surgical Oncology. 2021 Mar 1
• 11 citations
  FcγRIIB is a T cell checkpoint in antitumor immunity
  Clara R. Farley, Anna B. Morris, Marvi Tariq, Kelsey B Bennion, Sayalee Potdar, Ragini R. Kudchadkar, Michael C. Lowe, Mandy L. Ford> ;JCI Insight. 2021 Feb 22
• 11 citations
  Safety and efficacy of combination nivolumab plus ipilimumab in patients with advanced melanoma: results from a North American expanded access program (CheckMate 218).
  F. Stephen Hodi, Paul B. Chapman, Mario Sznol, Christopher D. Lao, Rene Gonzalez, Michael Smylie, Gregory A. Daniels, John A. Thompson, Ragini R. Kudchadkar, William H...> ;Melanoma Research. 2021 Feb 1
• 14 citations
  Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic Merkel cell carcinoma
  Chase W. Kwon, Rajini K. Murthy, Ragini R. Kudchadkar, Benjamin K. Stoff> ;JAAD Case Reports. 2020 Sep 19
• 3 citations
  Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases
  Cecilia Jiang, David G. Wallington, Christopher J. Anker, David H. Lawson, Melinda L. Yushak, Ragini R. Kudchadkar, Ahmad A Tarhini, Mohammad K. Khan> ;Neurosurgery. 2020 Sep 1
• 2 citations
  Neoadjuvant Therapy for Melanoma.
  Michael C. Lowe, Ragini R. Kudchadkar> ;Surgical Oncology Clinics of North America. 2020 Jul 1
• 105 citations
  Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study
  Reinhard Dummer, A Guminksi, Ralf Gutzmer, John T. Lear, Karl D. Lewis, Anne Lynn S. Chang, Patrick Combemale, Luc Dirix, Martin Kaatz, Ragini R. Kudchadkar, Carmen Lo...> ;The British Journal of Dermatology. 2020 Jun 1
• 122 citations
  Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial
  Suzanne L. Topalian, Shailender Bhatia, Asim Amin, Ragini R. Kudchadkar, William H. Sharfman, Céleste Lebbé, Jean Pierre Delord, Lara Dunn, Michi M. Shinohara, Rima M....> ;Journal of Clinical Oncology. 2020 Apr 23
• 156 citations
  Systemic Therapy for Melanoma: ASCO Guideline.
  Rahul Seth, Hans Messersmith, Varinder Kaur, John M. Kirkwood, Ragini R. Kudchadkar, Jennifer L. McQuade, Anthony F. Provenzano, Umang Swami, Jeffrey S. Weber, Krishna...> ;Journal of Clinical Oncology. 2020 Mar 31
• 50 citations
  Metastatic melanoma.
  Ragini R Kudchadkar, Michael C Lowe, Mohammad K Khan, Stephanie M McBrien> ;CA. 2020 Mar 1
• Join now to see all